Global Burden, Socio-demographic Index Correlations, and Mendelian Randomization Analysis of Risk Factors in Ischemic Heart Disease: A Comprehensive Study Based on GBD 2021 Data
DOI:
https://doi.org/10.64904/fpm25003Keywords:
Ischemic heart disease, Global Burden of Disease, Socio-demographic Index, Risk factors, Mendelian randomizationAbstract
Objective
Based on GBD 2021 data, to analyze the global trends in the burden of ischemic heart disease (IHD) from 1990 to 2021, its association with the Socio-demographic Index (SDI), and to evaluate the causal effects of risk factors.
Methods
IHD epidemiology and risk factor data from 204 countries and territories globally were extracted. Age-standardized rates (ASR) and average annual percentage change (AAPC) were calculated. Joinpoint regression, Mendelian randomization (MR), and ARIMA models were employed for trend analysis, causal inference, and prediction.
Results
Globally, the age-standardized incidence, mortality, and DALY rates of IHD declined (AAPC: -0.379, -1.200, and -1.083, respectively), while the prevalence rate slightly increased (AAPC: 0.040).North Africa, the Middle East, and Central Asia had the heaviest burden, while low-middle SDI regions had the highest incidence and prevalence rates.MR showed that smoking, high BMI, high waist-to-hip ratio, and high triglycerides increase IHD risk, while LDL-C had a protective effect (OR=0.996, p=0.006).Predictions indicate that the disease burden among females will continue to worsen in the future.
Conclusion
The burden of IHD is closely associated with SDI, necessitating targeted prevention and control strategies for low-middle SDI regions and addressing gender disparities.
References
[1] Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375. Epub 2019 Jun 4. PMID: 31163980; PMCID: PMC6613716. DOI: https://doi.org/10.1161/CIRCOUTCOMES.118.005375
[2] Sirajuddin A, Mirmomen SM, Kligerman SJ, Groves DW, Burke AP, Kureshi F, White CS, Arai AE. Ischemic Heart Disease: Noninvasive Imaging Techniques and Findings. Radiographics. 2021 Jul-Aug;41(4):990-1021. doi: 10.1148/rg.2021200125. Epub 2021 May 21. PMID: 34019437; PMCID: PMC8262179. DOI: https://doi.org/10.1148/rg.2021200125
[3] Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi SA, Almasi-Hashiani A, Sullman MJM, Mansournia MA, Bragazzi NL, Kaufman JS, Collins GS, Kolahi AA. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019. Eur J Prev Cardiol. 2022 Mar 11;29(2):420-431. doi: 10.1093/eurjpc/zwab213. PMID: 34922374. DOI: https://doi.org/10.1093/eurjpc/zwab213
[4] Montone RA, Camilli M, Calvieri C, Magnani G, Bonanni A, Bhatt DL, Rajagopalan S, Crea F, Niccoli G. Exposome in ischaemic heart disease: beyond traditional risk factors. Eur Heart J. 2024 Feb 7;45(6):419-438. doi: 10.1093/eurheartj/ehae001. PMID: 38238478; PMCID: PMC10849374. DOI: https://doi.org/10.1093/eurheartj/ehae001
[5] Zuin M, di Fusco SA, De Caterina R, Roncon L, Rigatelli G, Colivicchi F, Bilato C. Declining trends of premature mortality from ischemic heart disease and regional differences in Italy from 2011 to 2017. Int J Cardiol. 2023 Jul 15;383:110-116. doi: 10.1016/j.ijcard.2023.04.059. Epub 2023 May 9. PMID: 37164294. DOI: https://doi.org/10.1016/j.ijcard.2023.04.059
[6] Vancheri F, Tate AR, Henein M, Backlund L, Donfrancesco C, Palmieri L, Strender LE. Time trends in ischaemic heart disease incidence and mortality over three decades (1990-2019) in 20 Western European countries: systematic analysis of the Global Burden of Disease Study 2019. Eur J Prev Cardiol. 2022 Mar 11;29(2):396-403. doi: 10.1093/eurjpc/zwab134. PMID: 34487157. DOI: https://doi.org/10.1093/eurjpc/zwab134
[7] Islek D, Sozmen K, Unal B, Guzman-Castillo M, Vaartjes I, Critchley J, Capewell S, O'Flaherty M. Estimating the potential contribution of stroke treatments and preventative policies to reduce the stroke and ischemic heart disease mortality in Turkey up to 2032: a modelling study. BMC Public Health. 2016 Jan 19;16:46. doi: 10.1186/s12889-015-2655-8. PMID: 26781488; PMCID: PMC4717543. DOI: https://doi.org/10.1186/s12889-015-2655-8
[8] Tan EJ, Hayen A, Clarke P, Jackson R, Knight J, Hayes AJ. Trends in Ischaemic Heart Disease in Australia, 2001-2015: A Comparison of Urban and Rural Populations. Heart Lung Circ. 2021 Jul;30(7):971-977. doi: 10.1016/j.hlc.2020.11.009. Epub 2021 Jan 14. PMID: 33454212. DOI: https://doi.org/10.1016/j.hlc.2020.11.009
[9] Solola Nussbaum S, Henry S, Yong CM, Daugherty SL, Mehran R, Poppas A. Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7. J Am Coll Cardiol. 2022 Apr 12;79(14):1398-1406. doi: 10.1016/j.jacc.2021.11.065. PMID: 35393022; PMCID: PMC9009217. DOI: https://doi.org/10.1016/j.jacc.2021.11.065
[10] Virani S, Alonso A, Aparicio A, et al. Heart Disease and Stroke Statistics—2021 Update. A Report From the American Heart Association. Circulation 2021;143(8): e254–e743.
[11] Bergami M, Scarpone M, Cenko E, Varotti E, Amaduzzi PL, Manfrini O. Gender Differences in Non-Obstructive Coronary Artery Disease. Curr Pharm Des. 2021;27(29):3198-3209. doi: 10.2174/1381612826666201012163845. PMID: 33045960. DOI: https://doi.org/10.2174/1381612826666201012163845
[12] Chiha J, Mitchell P, Gopinath B, Plant AJH, Kovoor P, Thiagalingam A. Gender differences in the severity and extent of coronary artery disease. Int J Cardiol Heart Vasc. 2015;8:161-166. doi: 10.1016/j.ijcha.2015.07.009 DOI: https://doi.org/10.1016/j.ijcha.2015.07.009
[13] Reynolds HR, Shaw LJ, Min JK, Spertus JA, Chaitman BR, Berman DS, Picard MH, Kwong RY, Bairey-Merz CN, Cyr DD, Lopes RD, Lopez-Sendon JL, Held C, Szwed H, Senior R, Gosselin G, Nair RG, Elghamaz A, Bockeria O, Chen J, Chernyavskiy AM, Bhargava B, Newman JD, Hinic SB, Jaroch J, Hoye A, Berger J, Boden WE, O'Brien SM, Maron DJ, Hochman JS; ISCHEMIA Research Group. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol. 2020 Jul 1;5(7):773-786. doi: 10.1001/jamacardio.2020.0822. Erratum in: JAMA Cardiol. 2021 Aug 1;6(8):980. doi: 10.1001/jamacardio.2021.1509. PMID: 32227128; PMCID: PMC7105951. DOI: https://doi.org/10.1001/jamacardio.2020.0822
[14] Sullivan S, Young A, Garcia M, Almuwaqqat Z, Moazzami K, Hammadah M, Lima BB, Hu Y, Jajeh MN, Alkhoder A, Elon L, Lewis TT, Shah AJ, Mehta PK, Bremner JD, Quyyumi AA, Vaccarino V. Sex Differences in Vascular Response to Mental Stress and Adverse Cardiovascular Events Among Patients With Ischemic Heart Disease. Arterioscler Thromb Vasc Biol. 2023 Apr;43(4):e112-e120. doi: 10.1161/ATVBAHA.122.318576. Epub 2023 Mar 1. PMID: 36857628; PMCID: PMC10164352. DOI: https://doi.org/10.1161/ATVBAHA.122.318576
[15] Taqueti VR, Dorbala S, Wolinsky D et al. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol 2017; 24:1402–1426. DOI: https://doi.org/10.1007/s12350-017-0926-8
[16] Solola Nussbaum S, Henry S, Yong CM, Daugherty SL, Mehran R, Poppas A. Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7. J Am Coll Cardiol. 2022 Apr 12;79(14):1398-1406. doi: 10.1016/j.jacc.2021.11.065. PMID: 35393022; PMCID: PMC9009217. DOI: https://doi.org/10.1016/j.jacc.2021.11.065
[17] Park HB, Arsanjani R, Hong SJ, Yi JJ, Yi SW. Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population. Eur J Prev Cardiol. 2024 Feb 15;31(3):280-290. doi: 10.1093/eurjpc/zwad330. PMID: 37850354. DOI: https://doi.org/10.1093/eurjpc/zwad330
[18] Zhang W, Liu L, Yin G, Mohammed AQ, Xiang L, Lv X, Shi T, Galip J, Wang C, Mohammed AA, Mareai RM, Yu F, Abdu FA, Che W. Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease. Cardiovasc Diabetol. 2024 May 31;23(1):187. doi: 10.1186/s12933-024-02230-1. PMID: 38822373; PMCID: PMC11140859. DOI: https://doi.org/10.1186/s12933-024-02230-1
[19] Wikstrom K, Lindstrom J, Harald K, Peltonen M, Laatikainen T. Clinical and lifestyle‐related risk factors for incident multimorbidity: 10‐year follow‐up of Finnish population‐based cohorts 1982‐2012. Eur J Intern Med. 2015;26:211–216. doi: 10.1016/j.ejim.2015.02.012 DOI: https://doi.org/10.1016/j.ejim.2015.02.012
[20] Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, Sweeting M, Muller D, Romieu I, Bazelle P, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;18:5. doi: 10.1186/s12916-019-1474-7 DOI: https://doi.org/10.1186/s12916-019-1474-7
[21] Kobayashi Y, Yamagishi K, Muraki I, Kokubo Y, Saito I, Yatsuya H, Iso H, Tsugane S, Sawada N; JPHC Study Group. Secondhand smoke and the risk of incident cardiovascular disease among never-smoking women. Prev Med. 2022 Sep;162:107145. doi: 10.1016/j.ypmed.2022.107145. Epub 2022 Jul 5. Erratum in: Prev Med. 2023 Feb;167:107396. doi: 10.1016/j.ypmed.2022.107396. PMID: 35803355. DOI: https://doi.org/10.1016/j.ypmed.2022.107396
[22] Liu J, Wang S, Cui C, Cai H, Sun R, Pan W, Fang S, Yu B. The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction. Cardiovasc Diabetol. 2020 Jul 8;19(1):109. doi: 10.1186/s12933-020-01074-9. PMID: 32641042; PMCID: PMC7341636. DOI: https://doi.org/10.1186/s12933-020-01074-9
Downloads
Published
License
Copyright (c) 2025 Frontiers in Preventive Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
